Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT03511846

Pain Biomarker Study

The Pain Biomarker Study: Changes in Circulating Pain Signalling Molecules With Activation of Pain Receptors

Status
Enrolling By Invitation
Phase
Phase 1
Study type
Interventional
Enrollment
371 (estimated)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study investigates molecular and physical biomarkers of headaches in order to better understand mechanisms of these diseases. There are 3 main parts: 1. Use of capsaicin (active ingredient in hot chili peppers) to trigger release of calcitonin gene related peptide - the hypothesis is that this will be different in headache subjects compared to controls (and if so might be used to predict how these patients will respond to certain medications that modulate calcitonin gene-related peptide). Subjects will be given capsaicin as a cream applied to the forehead or the inner nostril, or a hot sauce that is ingested. 2. Use of capsaicin to trigger eye watering - the hypothesis is that oxygen gas will slow down the amount of eye watering. Cluster headache patients respond very powerfully to oxygen gas but to very little else. The mechanism for oxygen is unknown but in rodents there is data that it works on the parasympathetic / lacrimal gland system. This study translates rodent data into humans in a non-invasive way to confirm the mechanism of this very effective treatment. 3. Use of ice water to trigger headaches - brain freeze causes a very short-lived but intense headache that may cause similar biomarker release as other headache disorders. This may be a useful human model for other headache disorders.

Conditions

Interventions

TypeNameDescription
DRUGOral capsaicinSubjects will drink a solution with capsaicin
DRUGTopical capsaicinCapsaicin cream will be applied to the skin of the forehead, cheek, or leg
DRUGIntranasal capsaicinCapsaicin cream will be applied to the nostril
OTHERCold Water IrrigationSubjects will be asked to drink up to 2000 ml of cold water or ice water (temperature 0-10 degrees Celsius) as fast as possible, either continuously or intermittently (i.e. 200-800 ml at a time)
OTHERMedical AirSubjects will be exposed to medical air
DRUGLow Flow OxygenSubjects will be exposed to oxygen gas between 1-9 L/min
DRUGHigh Flow OxygenSubjects will be exposed to oxygen gas between 10-25 L/min

Timeline

Start date
2018-03-21
Primary completion
2028-05-31
Completion
2028-05-31
First posted
2018-04-30
Last updated
2026-02-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03511846. Inclusion in this directory is not an endorsement.